Literature DB >> 22489616

Zebrafish (Danio rerio) larvae as a system to test the efficacy of polysaccharides as immunostimulants.

U Oyarbide1, S Rainieri, M A Pardo.   

Abstract

The present study was carried out to examine the use of zebrafish (Danio rerio) as a preliminary screening model for testing the effect of potential immunostimulant substances on the innate immune system. β-Glucan, a polysaccharide used widely as an immunostimulant, was used as a representative molecule and tested on zebrafish embryos and larvae. The efficacy of the molecule was evaluated by determining the differential expression of some selected genes related to the immune system by RT-qPCR. Larvae from 72 hours post fertilization were found at the optimal developmental stage for assessing the expression of the selected genes. To verify if the β-glucan entered the larvae and therefore was responsible for the effects produced, the molecule was labeled fluorescently to check its localization by using microscopy. For estimating the effects of β-glucan on gene expression, zebrafish embryos and larvae were immersed in three different concentrations of β-glucan (50, 100, and 150 μg/mL) using five different exposure times. A stronger gene induction was observed when longer times of exposure and older larvae were used. The most evident effects of β-glucan were the overexpression of the genes TNFα, MPO, TRF, and LYZ. Moreover, slight changes in MPO expression were detected using a transgenic line of zebrafish (MPO::GFP), and a temporal increase in resistance against Vibrio anguillarum was found after β-glucan immersion. The assay used in this study permits the testing potential of immunostimulants in a simple and cost-effective way.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22489616     DOI: 10.1089/zeb.2011.0724

Source DB:  PubMed          Journal:  Zebrafish        ISSN: 1545-8547            Impact factor:   1.985


  8 in total

1.  Use of gnotobiotic zebrafish to study Vibrio anguillarum pathogenicity.

Authors:  Usua Oyarbide; Iñaki Iturria; Sandra Rainieri; Miguel Angel Pardo
Journal:  Zebrafish       Date:  2014-12-30       Impact factor: 1.985

2.  Phage therapy as an approach to prevent Vibrio anguillarum infections in fish larvae production.

Authors:  Yolanda J Silva; Liliana Costa; Carla Pereira; Cristiana Mateus; Angela Cunha; Ricardo Calado; Newton C M Gomes; Miguel A Pardo; Igor Hernandez; Adelaide Almeida
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

3.  Protective Yeasts Control V. anguillarum Pathogenicity and Modulate the Innate Immune Response of Challenged Zebrafish (Danio rerio) Larvae.

Authors:  Mario Caruffo; Natalie C Navarrete; Oscar A Salgado; Nelly B Faúndez; Miguel C Gajardo; Carmen G Feijóo; Angélica Reyes-Jara; Katherine García; Paola Navarrete
Journal:  Front Cell Infect Microbiol       Date:  2016-10-14       Impact factor: 5.293

4.  Biological Activity of Porcine Gastric Mucin on Stress Resistance and Immunomodulation.

Authors:  Thiloma D Liyanage; Pasan S Dahanayake; Shan L Edirisinghe; Chamilani Nikapitiya; Gang-Joon Heo; Mahanama De Zoysa; Ilson Whang
Journal:  Molecules       Date:  2020-06-29       Impact factor: 4.411

Review 5.  Trained Innate Immunity of Fish Is a Viable Approach in Larval Aquaculture.

Authors:  Zuobing Zhang; Heng Chi; Roy A Dalmo
Journal:  Front Immunol       Date:  2019-01-25       Impact factor: 7.561

6.  Effect of Treating Eggs with Coenzyme Q10 (CoQ10) on Growth Variables, Histomorphometry, and Antioxidant Capacity in Red Tilapia (Oreochromis aureus × Oreochromis mossambicus) Larvae.

Authors:  Mona M Mourad; Shimaa A Shahin; Ibrahim T El-Ratel; Mohammed F El Basuini
Journal:  Animals (Basel)       Date:  2022-08-29       Impact factor: 3.231

7.  Zebrafish as animal model for aquaculture nutrition research.

Authors:  Pilar E Ulloa; Juan F Medrano; Carmen G Feijoo
Journal:  Front Genet       Date:  2014-09-10       Impact factor: 4.599

Review 8.  Feed, Microbiota, and Gut Immunity: Using the Zebrafish Model to Understand Fish Health.

Authors:  Adrià López Nadal; Wakako Ikeda-Ohtsubo; Detmer Sipkema; David Peggs; Charles McGurk; Maria Forlenza; Geert F Wiegertjes; Sylvia Brugman
Journal:  Front Immunol       Date:  2020-02-05       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.